Management of Head Injury and NSAID Use

Introduction to Head Injury Management

The American Heart Association/American Stroke Association guidelines state that regular long-term use of NSAIDs is potentially harmful in patients with intracranial hemorrhage due to increased bleeding risk 1
Diclofenac carries elevated hemorrhagic stroke risk compared to other NSAIDs, with a large meta-analysis demonstrating increased risk of intracranial hemorrhage with diclofenac and meloxicam use 1

Acetaminophen should be first-line for pain management in trauma patients, including those with head injuries 2
If acetaminophen is contraindicated, ketorolac may be considered as an alternative NSAID with careful monitoring, though this represents short-term use rather than chronic administration 3
Opioid-sparing strategies are preferable in head injury patients to avoid masking neurological deterioration 3

Patients on antiplatelet agents have significantly elevated risk of intracranial injury after head trauma 4
The mechanism of platelet inhibition is relevant to bleeding risk, as demonstrated by studies on chronic antiplatelet use rather than acute NSAID administration 5

For patients with head injury requiring analgesia, first-line treatment should be acetaminophen at regular intervals for adequate pain control 2
If acetaminophen is insufficient or contraindicated, consider short-term opioids for moderate-severe pain or ketorolac for brief duration if opioids are contraindicated 2, 3
Avoid diclofenac and other NSAIDs for regular long-term use in patients with history of intracranial hemorrhage, patients with documented intracranial bleeding on imaging, and elderly patients with head trauma 1, 6, 7

The evidence specifically addresses chronic/regular NSAID use rather than single-dose or very short-term administration 1
No absolute contraindication exists for single-dose diclofenac in minor head injury without intracranial bleeding, though safer alternatives are preferred 1
If NSAIDs must be used, co-prescribe proton pump inhibitors to reduce gastrointestinal complications, and monitor renal function closely 2
Recombinant factor VIIa use in isolated head injury has been shown to be harmful, increasing mortality risk regardless of injury severity 6

The World Journal of Emergency Surgery recommends avoiding both diclofenac and etoricoxib in patients with hematoma, impaired renal function, and potential liver dysfunction, and instead using acetaminophen as first-line therapy, with short-term opioids as an alternative if necessary 8, 9

Both diclofenac and etoricoxib are contraindicated or require extreme caution in patients with impaired renal function, according to the World Journal of Emergency Surgery 8, 9
NSAIDs can worsen renal function in patients with chronic kidney disease or those taking nephrotoxic drugs, and can precipitate or worsen heart failure, as reported in the European Heart Journal 10

Diclofenac carries specific warnings for hepatotoxicity and should be avoided in patients with liver dysfunction, as stated in the American Family Physician 11

Both agents provoke arterial hypertension, edema, and heart failure, according to the European Heart Journal 10

Regular intravenous acetaminophen every 6 hours is effective for pain relief and should be first-line, as recommended by the World Journal of Emergency Surgery 8, 9

If acetaminophen is insufficient, consider short-term opioids (fentanyl, morphine) for moderate to severe pain with careful monitoring, as suggested by the World Journal of Emergency Surgery 8, 9

If NSAIDs must be used despite contraindications, co-prescribe a proton pump inhibitor, as recommended by the World Journal of Emergency Surgery 8, 9
Avoid combination with anticoagulants, antiplatelets, thrombolytics, SNRIs, or SSRIs, as warned by the European Heart Journal 10